1. Home
  2. META vs NVS Comparison

META vs NVS Comparison

Compare META & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meta Platforms Inc.

META

Meta Platforms Inc.

HOLD

Current Price

$627.03

Market Cap

1.7T

Sector

Technology

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$154.42

Market Cap

310.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
META
NVS
Founded
2004
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7T
310.4B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
META
NVS
Price
$627.03
$154.42
Analyst Decision
Strong Buy
Hold
Analyst Count
41
4
Target Price
$835.77
$118.00
AVG Volume (30 Days)
7.9M
2.3M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
0.35%
2.00%
EPS Growth
N/A
N/A
EPS
23.49
N/A
Revenue
$40,653,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$18.27
$4.91
P/E Ratio
$26.69
$23.13
Revenue Growth
47.09
N/A
52 Week Low
$479.80
$97.72
52 Week High
$796.25
$170.46

Technical Indicators

Market Signals
Indicator
META
NVS
Relative Strength Index (RSI) 42.29 42.56
Support Level $600.00 $113.19
Resistance Level $674.35 $158.80
Average True Range (ATR) 15.06 2.46
MACD -2.77 -1.99
Stochastic Oscillator 27.62 9.09

Price Performance

Historical Comparison
META
NVS

About META Meta Platforms Inc.

Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: